Janux Therapeutics Inc (JANX NASDAQ) stock market data APIs
$24.3123
-0.42(-1.7%)
as of September 18, 2025
Try our APIs with
free plan!
Janux Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer. Its clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor that is in Phase 1 clinical trial for the treatment of various solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. Janux Therapeutics, Inc. has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. The company was incorporated in 2017 and is headquartered in San Diego, California.
Prev. Close
24.3123
Open
23.8874
High
24.6024
Low
24.0497
52 wk Range
21.971-71.71
Market Cap
1 410 M
Shares Outstanding
60 094 K
Revenue
439 K
EPS
-0.55
Beta
2.837
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Janux Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Janux Therapeutics Inc data using free add-ons & libraries
Get Janux Therapeutics Inc Fundamental Data
Janux Therapeutics Inc Fundamental data includes:
- Net Revenue: 439 K
- EBITDA: -142 796 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: -0.4612
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Janux Therapeutics Inc News
New
Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT
Janux Therapeutics Inc. (NASDAQ:JANX) is one of the best up and coming stocks with huge upside potential. On September 10, Truist initiated coverage of Janux Therapeutics with a Buy rating and $100 pr...
Janux is a new Buy at Truist ahead of catalyst rich H2
[Usa ready for a stock market crash] franckreporter Truist Securities launched its coverage of Janux Therapeutics (NASDAQ:JANX [https://seekingalpha.com/symbol/JANX]) with a Buy recommendation and a ...
Synopsys downgraded, Oracle upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...
Summit draws Neutral view on risk/reward setup as Piper initiates biotech cancer names
[Wall Street sign in Lower Manhattan, NYC] georgeclerk Piper Sandler launched the coverage of a raft of cancer-focused biotechs with bullish views on Monday while issuing a Neutral recommendation on ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
